国药一致 (000028)

China National Accord Medicines Corporation Ltd.

ASZ

Tags

CSI Central State-Owned Enterprises IndexGeneric DrugsLow Price-to-Book RatioMedical Aesthetics ConceptPharmaceutical CommerceContains B-SharesSmart HealthcareBelow Net Asset ValueSocial Security HeavyHigh-Performing StocksHigh Accounts ReceivableShenzhen ConnectCSFC HoldingsPharma & BiotechStable Growth IndexSZSE Enterprises Composite IndexSZSE Medicine Equal Weight IndexInnovation Demonstration IndexSina 100 IndexShenzhen A-Share Pharmaceutical IndexCSI All-share Pharmaceutical Sector IndexSZSE 700 IndexCSRC Central Enterprises Small-cap IndexSZSE GDP IndexSZSE 1000 IndexCSSW Health IndexSZSE Component Index ReturnMedical Consumables Supply Chain SPDFTSE Russell ConceptHuijin ConceptStocks Below Book ValueWholesale & Retail IndexSZSE Selected IndexSZSE Responsibility IndexSME Board Innovation IndexCSRC Central Enterprises Composite IndexSZSE Pharmaceutical IndexCS Pharmaceutical TI IndexCSI 1000 IndexCNI Pharmaceutical IndexSZSE Component Pharmaceutical IndexCSI All-share Pharmaceutical IndexSZSE Pharmaceutical 50 IndexSZSE Component Index Equal WeightPharmaceutical & Health 100 IndexAH Economic Blue-chip IndexSZSE Fundamental 200 IndexStructural Adjustment IndexChina Economic Index GDPCSI 1000 Value IndexSZSE Fundamental 120 IndexCSI 1000 Value Stable IndexFundamental 600 IndexGuangdong

K-Line Chart

No K-line data available

Company NameChina National Pharmaceutical Group Co., Ltd. Yizheng Pharmaceutical Co., Ltd.
Listing Date1993-08-09
Issue Price3.5RMB
Registered Capital55656.507710k RMB
Legal RepresentativeWu Yijian
Registered AddressYizheng Pharmaceutical Building, No. 15 Bagua 4th Road, Yuanling Street, Futian District, Shenzhen City, Guangdong Province
IndustryPharmaceutical Commerce
Main BusinessPharmaceutical Distribution and Pharmaceutical Retail
Company ProfileChina National Pharmaceutical Group Co., Ltd. Yizheng Pharmaceutical Co., Ltd. owns the national cross-regional pharmaceutical retail chain brand "Guoda Pharmacy". It has established 29 regional chain companies in 19 provinces, autonomous regions, and municipalities directly under the central government, covering nearly 70 large and medium-sized cities, with over 4,000 retail pharmacies. In recent years, Guoda Pharmacy has adapted to social development, continuously improved its professional level, and launched chronic disease management services for diabetes, hypertension, etc.; actively responded to the "Internet+" trend by initiating the construction of health service apps and online health communities; persisted in service innovation, and deployed innovative retail diagnosis and treatment stores covering traditional Chinese medicine, Western medicine, TCM, Western medicine, rehabilitation physiotherapy, and various medical-related resources, striving to build a trusted Chinese pharmaceutical and health retail brand for consumers.

Stock Details

1. Key Indicators

  • Total Shares(W): 55656.51
  • Circulating A-Shares(W): 47805.37
  • Earnings Per Share(RMB): 1.7200
  • Net Assets Per Share(RMB): 33.1137
  • Operating Revenue(W RMB): 5512449.07
  • Total Profit(W RMB): 131765.48
  • Net Profit Attributable to Parent(W RMB): 95711.85
  • Net Profit Growth Rate(%): -10.18
  • Weighted Return on Equity(%): 5.2900
  • Operating Cash Flow Per Share(RMB): -0.8320
  • Undistributed Profit Per Share(RMB): 23.9486
  • Capital Reserve Per Share(RMB): 7.6678

2. Main Business

The main business covers:

  • Pharmaceutical Distribution
  • Pharmaceutical Retail

3. Company Basic Information

  • Company Name: China National Accord Medicines Corporation Ltd.
  • Listing Date: 1993-08-09
  • Industry: Pharmaceutical Commerce (CSRC Industry: Wholesale Trade)
  • Address: 15 Accord Pharmaceutical Building, Bagua 4th Road, Futian District, Shenzhen City, Guangdong Province
  • Website: www.szaccord.com.cn
  • Company Profile：The company's predecessor was Shenzhen Mineral Water Factory. In February 1993, it began restructuring into a joint-stock company, converting part of its net assets into 45.5 million state-owned shares. After an initial public offering from May to June of the same year, the total number of shares upon listing was 105 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Sinopharm Group Co., Ltd. General Legal Person 30484.25 63.77
2 National Social Security Fund Portfolio 413 Social Security Fund 779.99 1.63
3 China National Medicines Foreign Trade Corporation General Legal Person 692.00 1.45
4 National Social Security Fund Portfolio 401 Social Security Fund 386.12 0.81
5 Hong Kong Securities Clearing Company Ltd. Northbound Capital 241.16 0.50
6 Guolian An Fund - China Pacific Life Insurance Co., Ltd. - Participating Policy - Guolian An Fund China Pacific Life Equity Relative Return (Participating) Single Asset Management Plan Asset Management Plan 218.20 0.46
7 Southern China Securities 1000 Exchange Traded Open-End Index Securities Investment Fund Fund 178.76 0.37
8 <值> <值> <值> <值>
9 <值> <值> <值> <值>
10 <值> <值> <值> <值>

5. Concept Sectors

  • B-Share Included
  • Smart Healthcare
  • Generic Drugs
  • Medical Aesthetics Concept
  • Cold Chain Logistics
  • Margin Trading & Securities Lending
  • Low Price-to-Book Ratio
  • Blue-Chip Stock
  • Below Net Asset Value
  • High Accounts Receivable
  • CSI Central SOEs

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information